Rani-Logo.jpg
Rani Therapeutics to Present Abstract on RT-102 at the 2023 Annual Meeting of the American Society for Bone and Mineral Research
12. Oktober 2023 16:05 ET | Rani Therapeutics, LLC
SAN JOSE, Calif., Oct. 12, 2023 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...
Global Osteogenesis Imperfecta Treatment Market
Global Osteogenesis Imperfecta Treatment Market Set to Reach $850.5 Million by 2030, Fueled by Innovations in OI Therapies
07. September 2023 07:03 ET | Research and Markets
Dublin, Sept. 07, 2023 (GLOBE NEWSWIRE) -- The "Osteogenesis Imperfecta Treatment Market, By Drugs By Route of Administration, and By Region- Size, Share, Outlook, and Opportunity Analysis, 2023 -...
22157.jpg
Global Osteoporosis Disease Analysis Market Report 2020: Novartis has the Highest Number of Completed Clinical Trials for Osteoporosis with 120 Trials
01. Februar 2021 06:38 ET | Research and Markets
Dublin, Feb. 01, 2021 (GLOBE NEWSWIRE) -- The "Disease Analysis: Osteoporosis" report has been added to ResearchAndMarkets.com's offering. Osteoporosis is the most common metabolic bone disease, and...